Carregant...
Extended real-world experience with the ILUVIEN® (fluocinolone acetonide) implant in the United Kingdom: 3-year results from the Medisoft® audit study
BACKGROUND: This study aimed to assess the long-term effectiveness of the 0.2 μg/day fluocinolone acetonide (FAc) implant over ≥3 years for patients with diabetic macular oedema. METHODS: A retrospective audit of pseudo-anonymised data from patients with chronic diabetic macular oedema (cDMO) and tr...
Guardat en:
| Publicat a: | Eye (Lond) |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group UK
2021
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8107780/ https://ncbi.nlm.nih.gov/pubmed/33972705 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41433-021-01542-w |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|